Approved for Paricalcitol is a vitamin D analog indicated in adults for the prevention and treatment of secondary hyperparathyroidism associated with: Chronic kidney disease (CKD) Stages 3 and 4 ( 1.1 ). CKD Stage 5 in patients on hemodialysis or peritoneal dialysis ( 1.2 ).. Secondary hyperparathyroidism is characterized by an elevation in parathyroid hormone (PTH) associated with inadequate…
Loading full data from Know Your Drugs Institute…